Browse 24839 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
September 7th, 2021 |
Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2021 |
Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
April 9th, 2018 |
Sustainable Healthcenter Implementation Pre-Exposure Prophylaxis (PrEP) Pilot (SHIPP) |
Centers for Disease Control NCHHSTP |
August 1st, 2018 |
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21 Clinical Trial Optional) |
National Institutes of Health |
November 19th, 2020 |
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
May 30th, 2018 |
Provision of Technical Assistance and Training Activities to Assure Comprehensive Cancer Control Outcomes |
Centers for Disease Control NCCDPHP |
January 7th, 2021 |
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) |
National Institutes of Health |
May 26th, 2020 |
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
May 31st, 2018 |
Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) Program (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2021 |
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2021 |
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2021 |
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) |
National Institutes of Health |
July 25th, 2018 |
Workshop on the Use of Adolescent Brain Cognitive Development (ABCD) Data (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2021 |
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) |
National Institutes of Health |
June 15th, 2018 |
State Essentials for Childhood Initiative: Implementation of Strategies and Approaches for Child Abuse and Neglect Prevention |
Centers for Disease Control NCIPC |
June 11th, 2020 |
NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2021 |
Generating New insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 29th, 2018 |
Health Careers Opportunity Program: The National HCOP Academies |
Health Resources and Services Administration |
June 18th, 2018 |
Networking2Save: CDCs National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations |
Centers for Disease Control NCCDPHP |
May 7th, 2021 |
Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional) |
National Institutes of Health |
|
September 27th, 2018 |
NIH Director's Early Independence Award (DP5 - Clinical Trial Optional) |
National Institutes of Health |
May 22nd, 2018 |
Newborn Screening Data Repository and Technical Assistance Program |
Health Resources and Services Administration |
August 23rd, 2018 |
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) |
National Institutes of Health |
May 17th, 2018 |
International Bioethics Research Training Program (D43 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2021 |
NIA Limited Competition: Renewals of, and Revisions to, Existing Alzheimer's Disease Patient Registry Cooperative Agreement Awards (U01 - Clinical Trial Not Allowed) |
National Institutes of Health |
April 25th, 2018 |
Request for Information: USAID/DRC's WASH Planning |
Agency for International Development |
August 15th, 2018 |
Coordinating Center to Support NIDA Rural Opioid HIV and Comorbidity Initiative (U24 - Clinical Trial Not Allowed) |
National Institutes of Health |
May 16th, 2018 |
Reaching Healthcare Professionals in the Prevention of Fetal Alcohol Spectrum Disorders through National Professional Organizations |
Centers for Disease Control NCBDDD |
October 22nd, 2018 |
Enhance Population Access to Comprehensive HIV/AIDS Services in order to Achieve HIV/AIDS Epidemic Control in the Democratic Republic of Congo (DRC), Specifically in Haut - Katanga under the President's Emergency Plan |
Centers for Disease Control CGH |
May 16th, 2018 |
Promoting Resources for Fetal Alcohol Spectrum Disorders Awareness and Prevention |
Centers for Disease Control NCBDDD |
September 4th, 2018 |
Supporting Laboratory Strengthening Activities and Partnerships for Countries Supported under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
October 2nd, 2018 |
Enhance Population Access to Comprehensive HIV/AIDS Services in Order to Achieve HIV/AIDS Epidemic Control in the Democratic Republic of Congo (DRC), Specifically in Kinshasa under the President's Emergency Plan for |
Centers for Disease Control CGH |
October 22nd, 2018 |
Building and Improving Laboratory Capacity and Quality in the Democratic Republic of Congo (DRC) under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
October 9th, 2018 |
Strengthening Vietnam's Indigenous Technical Assistance Capacity and Systems through Support for HIV/AIDS Clinical Mentorship and Health System Strengthening under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
November 13th, 2018 |
HIV Prevention, Care, and Treatment Support for Church-related Hospitals and Clinics in the Republic of Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
October 28th, 2018 |
Consolidating Efforts Towards HIV and TB Epidemic Control in the Kenya Prisons Service (KPS) through Scale Up of High Quality HIV and TB Services, Capacity Strengthening, and Health System Strengthening under PEPFAR |
Centers for Disease Control CGH |
August 14th, 2018 |
HIV-Focused Population Surveys in Countries Supported Under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
October 22nd, 2018 |
Scaling High Quality Laboratory Services for HIV Diagnosis, Care, Treatment and Monitoring in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
October 2nd, 2018 |
Initiative for TB/HIV Program Collaboration and Service Integration in the Central America Region under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
June 20th, 2018 |
Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U19 Clinical Trial Not Allowed) |
National Institutes of Health |